SG Americas Securities
BVS icon

SG Americas Securities’s Bioventus BVS Stock Holding History

SG Americas Securities’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,792
Closed -$80K – 3263
2025
Q4 		$80K Buy
+10,792
New +$77.6K ﹤0.01% 3279
2025
Q3 		– Sell
-14,290
Closed -$95K – 3396
2025
Q2 		$95K Buy
14,290
+283
+2% +$2.01K ﹤0.01% 2649
2025
Q1 		$128K Sell
14,007
-3,588
-20% -$35.8K ﹤0.01% 2865
2024
Q4 		$185K Sell
17,595
-227
-1% -$2.69K ﹤0.01% 2224
2024
Q3 		$213K Sell
17,822
-7,493
-30% -$64.8K ﹤0.01% 2438
2024
Q2 		$146K Buy
25,315
+12,684
+100% +$69.6K ﹤0.01% 2337
2024
Q1 		$66K Buy
+12,631
New +$61.7K ﹤0.01% 2679
2023
Q2 		– Sell
-11,862
Closed -$13K – 2369
2023
Q1 		$13K Sell
11,862
-1,538
-11% -$2.94K ﹤0.01% 3179
2022
Q4 		$35K Sell
13,400
-2,924
-18% -$12.8K ﹤0.01% 2884
2022
Q3 		$114K Buy
16,324
+3,059
+23% +$24K ﹤0.01% 2756
2022
Q2 		$90K Buy
+13,265
New +$135K ﹤0.01% 3155

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SG Americas Securities's BVS Position: Q1 2026 in Review

SG Americas Securities sold out of Bioventus (BVS) in Q1 2026, closing a stake of 10,792 shares — an estimated $80K sold.

SG Americas Securities first reported a position in BVS in Q2 2022 and held it in 11 quarters. The position peaked at $213K in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • SG Americas Securities reported no remaining Bioventus position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 10,792 Bioventus shares in Q1 2026, an estimated $80K.
  • SG Americas Securities first reported a position in Bioventus in Q2 2022 and held it in 11 quarters.
  • SG Americas Securities's Bioventus position peaked at $213K in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.